Drug Type Small molecule drug |
Synonyms- |
Mechanism CLK2 inhibitors(CDC like kinase 2 inhibitors), DYRK inhibitors(DYRK kinase inhibitors), PDGFR antagonists(Platelet-derived growth factor receptor antagonists) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma Multiforme | Preclinical | - | - |